Targeting epidermal growth factor receptor in head and neck cancer
- PMID: 12478546
- DOI: 10.1002/hed.10224
Targeting epidermal growth factor receptor in head and neck cancer
Abstract
It is well known that growth factors play an important role in normal cell proliferation by means of stimulation of growth factor receptors located on the surface of cells. Tumor cells express high levels of growth factor receptors that can theoretically serve as therapeutic targets in cancer treatment. Tyrosine kinase (type 1) growth factor receptors include the family of erbB receptors. The most extensively studied receptor in the erbB family is the human epidermal growth factor receptor (EGFR), also known as erbB1. Studies have shown that overexpression of EGFR is involved in the development and progression of head and neck squamous cell carcinoma (HNSCC). Blocking this receptor in HNSCC cell lines and animal models inhibits tumor growth. Strategies have been developed to target EGFR, including monoclonal antibodies, tyrosine kinase-specific inhibitors, ligand-linked immunotoxins, and antisense approaches. Laboratory studies and clinical trials are under way to explore the safety and efficacy of these various approaches in a variety of cancers, including HNSCC. Preliminary results from early phase clinical trials are encouraging and may lead to the incorporation of these EGFR targeting strategies into the management of HNSCC.
Copyright 2002 Wiley Periodicals, Inc.
Similar articles
-
AEE788: a dual family epidermal growth factor receptor/ErbB2 and vascular endothelial growth factor receptor tyrosine kinase inhibitor with antitumor and antiangiogenic activity.Cancer Res. 2004 Jul 15;64(14):4931-41. doi: 10.1158/0008-5472.CAN-03-3681. Cancer Res. 2004. PMID: 15256466
-
Rational bases for the development of EGFR inhibitors for cancer treatment.Int J Biochem Cell Biol. 2007;39(7-8):1416-31. doi: 10.1016/j.biocel.2007.05.008. Epub 2007 May 21. Int J Biochem Cell Biol. 2007. PMID: 17596994 Review.
-
Epidermal growth factor receptor and response of head-and-neck carcinoma to therapy.Int J Radiat Oncol Biol Phys. 2004 Mar 1;58(3):959-65. doi: 10.1016/j.ijrobp.2003.07.010. Int J Radiat Oncol Biol Phys. 2004. PMID: 14967456 Review.
-
Mutant epidermal growth factor receptor (EGFRvIII) contributes to head and neck cancer growth and resistance to EGFR targeting.Clin Cancer Res. 2006 Sep 1;12(17):5064-73. doi: 10.1158/1078-0432.CCR-06-0913. Clin Cancer Res. 2006. PMID: 16951222
-
Critical update and emerging trends in epidermal growth factor receptor targeting in cancer.J Clin Oncol. 2005 Apr 10;23(11):2445-59. doi: 10.1200/JCO.2005.11.890. Epub 2005 Mar 7. J Clin Oncol. 2005. PMID: 15753456 Review.
Cited by
-
Cetuximab and irinotecan interact synergistically to inhibit the growth of orthotopic anaplastic thyroid carcinoma xenografts in nude mice.Clin Cancer Res. 2006 Jan 15;12(2):600-7. doi: 10.1158/1078-0432.CCR-05-1325. Clin Cancer Res. 2006. PMID: 16428506 Free PMC article.
-
The role of human papillomavirus 16 E6 in anchorage-independent and invasive growth of mouse tonsil epithelium.Arch Otolaryngol Head Neck Surg. 2007 May;133(5):495-502. doi: 10.1001/archotol.133.5.495. Arch Otolaryngol Head Neck Surg. 2007. PMID: 17515506 Free PMC article.
-
Combination of phosphorylated and truncated EGFR correlates with higher tumor and nodal stage in head and neck cancer.Cancer Invest. 2010 Dec;28(10):1054-62. doi: 10.3109/07357907.2010.512602. Epub 2010 Sep 27. Cancer Invest. 2010. PMID: 20873989 Free PMC article.
-
Cetuximab: a review of its use in squamous cell carcinoma of the head and neck and metastatic colorectal cancer.Drugs. 2007;67(17):2585-607. doi: 10.2165/00003495-200767170-00008. Drugs. 2007. PMID: 18034592 Review.
-
Human Papillomavirus Regulates HER3 Expression in Head and Neck Cancer: Implications for Targeted HER3 Therapy in HPV+ Patients.Clin Cancer Res. 2017 Jun 15;23(12):3072-3083. doi: 10.1158/1078-0432.CCR-16-2203. Epub 2016 Dec 16. Clin Cancer Res. 2017. PMID: 27986750 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous